A carregar...
Non-inferiority Trials Using a Surrogate Marker as a Primary Endpoint: An Increasing Phenotype in Cardiovascular Trials
BACKGROUND/AIMS: Non-inferiority trials are increasing in cardiovascular medicine, with approval of many drugs and devices on the basis of such studies. Surrogate markers as primary endpoints have been also more frequently used for efficient assessment of cardiovascular interventions. However, there...
Na minha lista:
| Publicado no: | Clin Trials |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8088773/ https://ncbi.nlm.nih.gov/pubmed/32838556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1740774520949157 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|